Novartis Investing Big in Austrian Generics Plant
GALWAY, IRELAND--August 11, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Novartis is to expand its Kundl antibiotics facility following a deal with the Austrian government that will see an investment of 150 million euro ($176 million).
Within this article: Details new plant investment, proposed works, antibiotics production in Europe, industry support for new antibiotics research
